Timothy Christopher Shen, MD
Physical Medicine and Rehabilitation · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · California Sports and Orthopaedic
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · UCSF Health Hyde Hospital. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A75751 · Current
Licensed to practise in California · since 2001 · expires 2027-02-28 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- The Surgery Center of Alta Bates Summit Medical CenterAmbulatory Surgery Center · Oakland, CAOwner · accredited by JCInitial Accreditation4 inspections, 4 with deficiencies · last 2017-07-27: Requirements Met
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- UCSF Health Saint Francis HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.251, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for UCSF Health Saint Francis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.251 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 146 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.8 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 37 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 379 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,255 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,226 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.5 (1.04 to 5.97) · 221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.52 to 3.89) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.17 (0 to 16.08) · 111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.97 (0.74 to 9.21) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,068 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 35 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.499 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.7 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 54 · 84 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.1 to 18.1) · 87 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 35 cases | No different | Jan 2024 – Dec 2024 |
What patients said (217 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 61% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$219,995
Medicare paid this office $219,995 for 639 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 394 | $82,078 | $83 |
| Return visit (30+ min) | 321 | $40,912 | $117 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 182 | $28,587 | $119 |
| New patient visit (45+ min) | 137 | $20,617 | $150 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 122 | $7,931 | $50 |
See all 20 services
| Short return visit (20+ min) | 394 | $82,078 | $83 |
| Return visit (30+ min) | 321 | $40,912 | $117 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 182 | $28,587 | $119 |
| New patient visit (45+ min) | 137 | $20,617 | $150 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 122 | $7,931 | $50 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 43 | $4,714 | $96 |
| X-ray of lower and sacral spine, 2-3 views | 105 | $4,479 | $42 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 17 | $4,162 | $231 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 23 | $2,837 | $105 |
| Aspiration and/or injection of fluid from large joint | 29 | $2,731 | $64 |
| Muscle electrical test | 19 | $2,501 | $96 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 12 | $1,792 | $119 |
| Injection of trigger points, 1-2 muscles | 27 | $1,635 | $50 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 23 | $1,575 | $58 |
| X-ray of both hips, 2 views | 35 | $1,444 | $40 |
| Nerve test | 11 | $1,345 | $122 |
| X-ray of upper spine, 2-3 views | 32 | $1,291 | $40 |
| New patient visit (30+ min) | 12 | $1,276 | $106 |
| X-ray of middle spine, 2 views | 11 | $381 | $35 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 63 | $329 | None |
Who their Medicare patients are
639 Original Medicare patients in 2024. Average age 76 · Under 65 2% · 85 and older 12% · Women 63% · Also on Medicaid 8% · Health risk score 0.94. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 64% · Coronary heart disease 21% · Depression 21% · Chronic kidney disease 19% · Diabetes 18% · Cancer 16% · Atrial fibrillation 15% · Heart failure 8% · COPD 8% · Stroke 6% · Dementia 3%.
The office billed $701,910, Medicare allowed $286,653 and paid $219,995; for 3,926 services of 48 kinds; $1,411 of it was for drugs given in the office and $218,584 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 639 | 3,926 | 76 | 0.94 | $701,910 | $219,995 |
| 2023 | 620 | 2,640 | 76 | 0.97 | $644,155 | $198,770 |
| 2022 | 545 | 2,648 | 75 | 0.90 | $537,055 | $161,261 |
| 2021 | 496 | 2,431 | 74 | 0.95 | $466,568 | $152,961 |
| 2020 | 381 | 1,459 | 75 | 1.07 | $340,718 | $96,072 |
| 2019 | 535 | 1,863 | 73 | 1.05 | $540,591 | $144,233 |
| 2018 | 424 | 1,682 | 73 | 1.20 | $412,636 | $123,539 |
| 2017 | 447 | 1,687 | 73 | 1.14 | $422,998 | $119,530 |
| 2016 | 421 | 1,815 | 72 | 1.19 | $368,672 | $114,675 |
| 2015 | 431 | 1,585 | 74 | 1.23 | $345,894 | $112,723 |
| 2014 | 394 | 1,681 | 73 | 1.03 | $329,857 | $107,762 |
| 2013 | 391 | 1,508 | 72 | 1.11 | $320,301 | $103,796 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Short return visit (20+ min) | 362 | $73,091 | $80 |
| Return visit (30+ min) | 250 | $31,942 | $116 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 152 | $24,718 | $118 |
| New patient visit (45+ min) | 166 | $23,729 | $143 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 101 | $6,746 | $50 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 35 | $3,913 | $100 |
| X-ray of lower and sacral spine, 2-3 views | 87 | $3,454 | $40 |
| New patient visit (30+ min) | 40 | $2,883 | $72 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 11 | $2,689 | $224 |
| Muscle electrical test | 19 | $2,366 | $99 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $2,160 | $108 |
| Injection of trigger points, 1-2 muscles | 38 | $2,075 | $48 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 15 | $2,054 | $121 |
| Aspiration and/or injection of fluid from large joint | 24 | $1,934 | $67 |
| X-ray of upper spine, 2-3 views | 39 | $1,586 | $41 |
| Nerve test | 11 | $1,324 | $120 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 17 | $1,123 | $59 |
| X-ray of knee, 1-2 views | 16 | $933 | $36 |
| X-ray of both hips, 2 views | 23 | $904 | $39 |
| X-ray of shoulder, minimum of 2 views | 13 | $577 | $36 |
| X-ray of middle spine, 2 views | 11 | $375 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | $329 | None |
2022: 15 services
| Short return visit (20+ min) | 293 | $57,670 | $78 |
| New patient visit (45+ min) | 203 | $29,304 | $144 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 127 | $19,896 | $119 |
| New patient visit (30+ min) | 124 | $11,722 | $95 |
| Return visit (30+ min) | 70 | $8,260 | $112 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 73 | $4,461 | $49 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 35 | $3,515 | $95 |
| Muscle electrical test | 17 | $2,390 | $100 |
| Injection of trigger points, 1-2 muscles | 31 | $2,045 | $48 |
| Aspiration and/or injection of fluid from large joint | 20 | $2,025 | $68 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 17 | $1,923 | $101 |
| X-ray of lower and sacral spine, 2-3 views | 47 | $1,900 | $40 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $928 | $52 |
| X-ray of upper spine, 2-3 views | 22 | $871 | $40 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 50 | $294 | None |
2021: 15 services
| Short return visit (20+ min) | 276 | $55,967 | $80 |
| New patient visit (45+ min) | 193 | $28,923 | $150 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 129 | $18,965 | $119 |
| New patient visit (30+ min) | 99 | $10,225 | $103 |
| Return visit (30+ min) | 66 | $7,458 | $110 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 59 | $3,496 | $48 |
| Muscle electrical test | 17 | $2,494 | $104 |
| Aspiration and/or injection of fluid from large joint | 25 | $2,157 | $63 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 13 | $1,988 | $124 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 20 | $1,947 | $93 |
| Nerve test | 11 | $1,578 | $143 |
| Injection of trigger points, 1-2 muscles | 23 | $1,525 | $49 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $1,254 | $96 |
| X-ray of lower and sacral spine, 2-3 views | 23 | $943 | $41 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 44 | $249 | None |
2020: 13 services
| Short return visit (20+ min) | 231 | $35,452 | $60 |
| New patient visit (45+ min) | 133 | $17,323 | $130 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 93 | $13,739 | $111 |
| Return visit (30+ min) | 68 | $6,566 | $86 |
| New patient visit (30+ min) | 63 | $5,582 | $89 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 56 | $3,280 | $48 |
| Aspiration and/or injection of fluid from large joint | 14 | $1,479 | $57 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $1,434 | $102 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 13 | $1,268 | $91 |
| Short return visit | 22 | $1,127 | $40 |
| Injection of trigger points, 1-2 muscles | 13 | $530 | $41 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $399 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $190 | None |
2019: 16 services
| Short return visit (20+ min) | 268 | $41,440 | $62 |
| New patient visit (45+ min) | 280 | $36,340 | $130 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 142 | $23,770 | $113 |
| Return visit (30+ min) | 104 | $9,988 | $88 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 83 | $5,067 | $46 |
| New patient visit (30+ min) | 41 | $3,461 | $84 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 29 | $3,157 | $90 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 18 | $2,351 | $118 |
| Muscle electrical test | 16 | $2,059 | $90 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | $1,585 | $106 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,537 | $51 |
| Injection of trigger points, 1-2 muscles | 20 | $1,130 | $49 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $825 | $63 |
| X-ray of lower and sacral spine, 2-3 views | 21 | $730 | $35 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $125 | None |
| Injection, methylprednisolone acetate, 40 mg | 18 | $94 | None |
2018: 13 services
| Short return visit (20+ min) | 245 | $40,739 | $61 |
| New patient visit (45+ min) | 185 | $25,406 | $137 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 140 | $20,978 | $107 |
| Return visit (30+ min) | 66 | $5,495 | $78 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 86 | $5,453 | $47 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 12 | $3,787 | $237 |
| Muscle electrical test | 25 | $3,236 | $87 |
| Nerve test | 13 | $2,854 | $220 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 25 | $2,774 | $92 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 16 | $2,251 | $118 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 20 | $2,144 | $93 |
| Nerve test | 11 | $1,721 | $143 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 17 | $1,126 | $56 |
2017: 11 services
| Short return visit (20+ min) | 264 | $41,018 | $59 |
| New patient visit (45+ min) | 209 | $26,957 | $129 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 140 | $21,039 | $108 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 68 | $4,127 | $47 |
| Return visit (30+ min) | 47 | $3,821 | $81 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 29 | $3,190 | $97 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 20 | $2,530 | $110 |
| Muscle electrical test | 22 | $2,436 | $84 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 25 | $2,155 | $77 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 25 | $1,712 | $63 |
| Aspiration and/or injection of fluid from large joint | 12 | $735 | $53 |
2016: 11 services
| Short return visit (20+ min) | 241 | $37,220 | $60 |
| New patient visit (45+ min) | 189 | $25,190 | $133 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 141 | $21,439 | $110 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 70 | $4,441 | $46 |
| Return visit (30+ min) | 47 | $4,210 | $86 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 15 | $2,525 | $120 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 20 | $1,902 | $86 |
| Muscle electrical test | 12 | $1,625 | $86 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | $1,604 | $100 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $795 | $61 |
| Short return visit | 12 | $475 | $40 |
2015: 12 services
| Short return visit (20+ min) | 248 | $36,093 | $59 |
| New patient visit (45+ min) | 211 | $27,819 | $132 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 140 | $21,356 | $112 |
| Return visit (30+ min) | 57 | $4,995 | $86 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 67 | $3,990 | $48 |
| Muscle electrical test | 16 | $2,133 | $85 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 15 | $1,949 | $115 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | $1,472 | $92 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 14 | $1,345 | $96 |
| Injections of substances into lower or sacral spine | 12 | $1,116 | $74 |
| Aspiration and/or injection of fluid from large joint | 11 | $751 | $54 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $728 | $61 |
2014: 11 services
| Short return visit (20+ min) | 240 | $36,930 | $59 |
| New patient visit (45+ min) | 196 | $26,198 | $134 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 129 | $20,196 | $118 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 17 | $2,976 | $124 |
| Return visit (30+ min) | 32 | $2,724 | $80 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 21 | $2,267 | $99 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 40 | $2,256 | $47 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $1,435 | $96 |
| Muscle electrical test | 12 | $1,362 | $85 |
| New patient visit (30+ min) | 11 | $1,055 | $96 |
| Short return visit | 11 | $435 | $36 |
2013: 10 services
| Short return visit (20+ min) | 271 | $40,668 | $60 |
| New patient visit (45+ min) | 186 | $24,625 | $132 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 128 | $19,597 | $105 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 41 | $2,284 | $46 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 20 | $2,115 | $85 |
| Return visit (30+ min) | 20 | $1,687 | $80 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 16 | $1,603 | $80 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 11 | $1,436 | $120 |
| New patient visit (30+ min) | 13 | $1,262 | $97 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $808 | $58 |
Drugs they prescribed that Part D paid
$29,598
Pharmacies billed $29,598 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 42% of their Part D prescriptions (475 of 1,128) in 2024. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 3% of their opioid prescriptions.
1,104 generic and 24 brand-name prescriptions · $29,598 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diclofenac Epolamine | 21 | $8,504 | $405 |
| Hydrocodone-Acetaminophen | 225 | $4,054 | $18 |
| Gabapentin | 270 | $3,460 | $13 |
| Lidocaine | 22 | $3,207 | $146 |
| Oxycodone-Acetaminophen | 95 | $2,539 | $27 |
See all 18 drugs
| Diclofenac Epolamine | 21 | $8,504 | $405 |
| Hydrocodone-Acetaminophen | 225 | $4,054 | $18 |
| Gabapentin | 270 | $3,460 | $13 |
| Lidocaine | 22 | $3,207 | $146 |
| Oxycodone-Acetaminophen | 95 | $2,539 | $27 |
| Oxycodone | 68 | $1,698 | $25 |
| Diclofenac | 39 | $1,426 | $37 |
| Pregabalin | 31 | $890 | $29 |
| Celecoxib | 24 | $645 | $27 |
| Cyclobenzaprine | 73 | $629 | $9 |
| Tramadol | 67 | $237 | $4 |
| Ibuprofen | 39 | $224 | $6 |
| Baclofen | 15 | $223 | $15 |
| Carisoprodol | 12 | $153 | $13 |
| Meloxicam | 31 | $137 | $4 |
| Tizanidine | 18 | $104 | $6 |
| Diazepam | 23 | $85 | $4 |
| Morphine Sulfate Er | 12 | $44 | $4 |
Year by year
| 2024 | 1,128 | 225 | 42% (475) | 2% | $29,598 |
| 2023 | 1,060 | 194 | 45% (476) | 2% | $55,239 |
| 2022 | 972 | 152 | 49% (478) | 3% | $80,242 |
| 2021 | 872 | 149 | 58% (503) | 5% | $68,573 |
| 2020 | 876 | 140 | 66% (574) | 13% | $91,765 |
| 2019 | 789 | 131 | 71% (556) | 16% | $93,984 |
| 2018 | 827 | 120 | 76% (625) | 19% | $108,899 |
| 2017 | 953 | 135 | 72% (686) | 20% | $124,984 |
| 2016 | 857 | 130 | 69% (594) | 19% | $103,981 |
| 2015 | 793 | 125 | 70% (554) | 21% | $101,666 |
| 2014 | 847 | 117 | 72% (607) | 24% | $120,171 |
| 2013 | 939 | 163 | 73% (683) | 17% | $91,883 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Xtampza Er | 11 | $24,501 | $2,227 |
| Lidocaine | 24 | $5,544 | $231 |
| Gabapentin | 230 | $4,919 | $21 |
| Hydrocodone-Acetaminophen | 248 | $4,759 | $19 |
| Diclofenac | 51 | $3,068 | $60 |
| Oxycodone-Acetaminophen | 91 | $2,544 | $28 |
| Oxycodone | 55 | $1,237 | $22 |
| Pregabalin | 29 | $1,218 | $42 |
| Cyclobenzaprine | 59 | $849 | $14 |
| Tizanidine | 14 | $570 | $41 |
| Ibuprofen | 48 | $511 | $11 |
| Baclofen | 15 | $249 | $17 |
| Celecoxib | 15 | $159 | $11 |
| Tramadol | 45 | $145 | $3 |
| Meloxicam | 35 | $139 | $4 |
| Diazepam | 28 | $99 | $4 |
| Morphine Sulfate Er | 11 | $80 | $7 |
| Acetaminophen-Codeine | 13 | $61 | $5 |
2022: 18 drugs
| Xtampza Er | 26 | $53,721 | $2,066 |
| Hydrocodone-Acetaminophen | 236 | $5,102 | $22 |
| Gabapentin | 248 | $5,092 | $21 |
| Lidocaine | 17 | $4,912 | $289 |
| Oxycodone-Acetaminophen | 105 | $3,368 | $32 |
| Oxycodone | 57 | $2,273 | $40 |
| Diclofenac | 34 | $2,249 | $66 |
| Ibuprofen | 38 | $450 | $12 |
| Cyclobenzaprine | 29 | $410 | $14 |
| Tizanidine | 14 | $347 | $25 |
| Acetaminophen-Codeine | 19 | $304 | $16 |
| Morphine Sulfate Er | 11 | $234 | $21 |
| Baclofen | 18 | $232 | $13 |
| Naproxen | 12 | $132 | $11 |
| Meloxicam | 16 | $113 | $7 |
| Diazepam | 23 | $89 | $4 |
| Tramadol | 18 | $37 | $2 |
| Zolpidem | 12 | $15 | $1 |
2021: 16 drugs
| Xtampza Er | 23 | $41,140 | $1,789 |
| Oxycontin | 12 | $9,239 | $770 |
| Hydrocodone-Acetaminophen | 225 | $3,964 | $18 |
| Oxycodone-Acetaminophen | 137 | $3,538 | $26 |
| Gabapentin | 180 | $2,824 | $16 |
| Oxycodone | 48 | $1,462 | $30 |
| Pregabalin | 21 | $919 | $44 |
| Acetaminophen-Codeine | 25 | $456 | $18 |
| Diclofenac | 16 | $456 | $28 |
| Ibuprofen | 36 | $338 | $9 |
| Morphine Sulfate Er | 12 | $139 | $12 |
| Baclofen | 16 | $135 | $8 |
| Zolpidem | 11 | $69 | $6 |
| Cyclobenzaprine | 18 | $66 | $4 |
| Tramadol | 20 | $56 | $3 |
| Meloxicam | 13 | $53 | $4 |
2020: 15 drugs
| Oxycontin | 91 | $72,501 | $797 |
| Oxycodone-Acetaminophen | 145 | $5,452 | $38 |
| Hydrocodone-Acetaminophen | 182 | $3,203 | $18 |
| Gabapentin | 152 | $2,626 | $17 |
| Lidocaine | 14 | $2,140 | $153 |
| Oxycodone | 64 | $1,700 | $27 |
| Narcan | 12 | $1,557 | $130 |
| Pregabalin | 18 | $806 | $45 |
| Acetaminophen-Codeine | 34 | $325 | $10 |
| Morphine Sulfate Er | 21 | $237 | $11 |
| Diclofenac | 11 | $216 | $20 |
| Baclofen | 19 | $215 | $11 |
| Ibuprofen | 22 | $191 | $9 |
| Tramadol | 34 | $94 | $3 |
| Zolpidem | 13 | $86 | $7 |
2019: 13 drugs
| Oxycontin | 102 | $71,652 | $702 |
| Oxycodone-Acetaminophen | 129 | $5,860 | $45 |
| Gabapentin | 112 | $3,367 | $30 |
| Hydrocodone-Acetaminophen | 155 | $2,708 | $17 |
| Oxycodone | 75 | $2,071 | $28 |
| Narcan | 12 | $1,534 | $128 |
| Morphine Sulfate Er | 25 | $341 | $14 |
| Acetaminophen-Codeine | 29 | $293 | $10 |
| Ibuprofen | 20 | $190 | $10 |
| Methadone | 14 | $147 | $11 |
| Baclofen | 13 | $135 | $10 |
| Tramadol | 25 | $71 | $3 |
| Meloxicam | 16 | $51 | $3 |
2018: 10 drugs
| Oxycontin | 116 | $81,162 | $700 |
| Oxycodone-Acetaminophen | 155 | $8,471 | $55 |
| Hydrocodone-Acetaminophen | 211 | $4,025 | $19 |
| Gabapentin | 95 | $1,551 | $16 |
| Oxycodone | 58 | $1,403 | $24 |
| Morphine Sulfate Er | 15 | $441 | $29 |
| Methadone | 25 | $263 | $11 |
| Acetaminophen-Codeine | 18 | $168 | $9 |
| Ibu | 13 | $87 | $7 |
| Cyclobenzaprine | 16 | $44 | $3 |
2017: 16 drugs
| Oxycontin | 133 | $91,577 | $689 |
| Oxycodone-Acetaminophen | 136 | $8,263 | $61 |
| Lyrica | 14 | $5,916 | $423 |
| Hydrocodone-Acetaminophen | 186 | $3,854 | $21 |
| Morphine Sulfate Er | 52 | $2,267 | $44 |
| Oxycodone | 66 | $2,255 | $34 |
| Lidocaine | 14 | $1,403 | $100 |
| Endocet | 13 | $1,287 | $99 |
| Gabapentin | 71 | $1,029 | $14 |
| Methadone | 51 | $735 | $14 |
| Acetaminophen-Codeine | 19 | $313 | $16 |
| Tramadol | 24 | $125 | $5 |
| Ibu | 22 | $117 | $5 |
| Cyclobenzaprine | 27 | $99 | $4 |
| Meloxicam | 14 | $45 | $3 |
| Diazepam | 17 | $25 | $1 |
2016: 13 drugs
| Oxycontin | 117 | $74,246 | $635 |
| Oxycodone-Acetaminophen | 117 | $8,783 | $75 |
| Hydrocodone-Acetaminophen | 202 | $5,903 | $29 |
| Lyrica | 11 | $3,752 | $341 |
| Morphine Sulfate Er | 36 | $1,825 | $51 |
| Oxycodone | 36 | $1,271 | $35 |
| Gabapentin | 113 | $1,101 | $10 |
| Endocet | 12 | $1,081 | $90 |
| Methadone | 38 | $1,004 | $26 |
| Tramadol | 18 | $100 | $6 |
| Carisoprodol | 17 | $94 | $6 |
| Zolpidem | 15 | $76 | $5 |
| Cyclobenzaprine | 29 | $64 | $2 |
2015: 14 drugs
| Oxycontin | 125 | $71,087 | $569 |
| Oxycodone-Acetaminophen | 109 | $7,300 | $67 |
| Hydrocodone-Acetaminophen | 162 | $5,314 | $33 |
| Lyrica | 16 | $4,697 | $294 |
| Morphine Sulfate Er | 38 | $2,389 | $63 |
| Oxycodone | 59 | $1,597 | $27 |
| Endocet | 12 | $1,299 | $108 |
| Gabapentin | 78 | $839 | $11 |
| Cyclobenzaprine | 34 | $605 | $18 |
| Methadone | 24 | $499 | $21 |
| Ibuprofen | 19 | $161 | $8 |
| Carisoprodol | 19 | $116 | $6 |
| Tramadol | 17 | $79 | $5 |
| Zolpidem | 12 | $53 | $4 |
2014: 17 drugs
| Oxycontin | 130 | $77,175 | $594 |
| Kadian | 11 | $7,632 | $694 |
| Oxycodone-Acetaminophen | 105 | $7,373 | $70 |
| Lyrica | 24 | $5,680 | $237 |
| Hydrocodone-Acetaminophen | 178 | $4,436 | $25 |
| Endocet | 24 | $2,767 | $115 |
| Morphine Sulfate Er | 39 | $1,512 | $39 |
| Oxycodone | 53 | $1,179 | $22 |
| Gabapentin | 73 | $990 | $14 |
| Cyclobenzaprine | 14 | $312 | $22 |
| Methadone | 24 | $271 | $11 |
| Carisoprodol | 22 | $242 | $11 |
| Baclofen | 15 | $159 | $11 |
| Ibuprofen | 16 | $150 | $9 |
| Tramadol | 16 | $113 | $7 |
| Hydromorphone | 11 | $96 | $9 |
| Zolpidem | 11 | $59 | $5 |
2013: 16 drugs
| Oxycontin | 87 | $56,760 | $652 |
| Hydrocodone-Acetaminophen | 265 | $6,431 | $24 |
| Oxycodone Hcl-Acetaminophen | 100 | $6,114 | $61 |
| Morphine Sulfate Er | 46 | $1,788 | $39 |
| Endocet | 18 | $1,497 | $83 |
| Fentanyl | 13 | $1,388 | $107 |
| Gabapentin | 81 | $1,004 | $12 |
| Carisoprodol | 37 | $445 | $12 |
| Cyclobenzaprine | 27 | $372 | $14 |
| Oxycodone | 17 | $335 | $20 |
| Hydromorphone | 26 | $267 | $10 |
| Tramadol | 27 | $256 | $9 |
| Methadone | 27 | $222 | $8 |
| Oxycodone-Acetaminophen | 16 | $187 | $12 |
| Ibuprofen | 22 | $186 | $8 |
| Roxicet | 14 | $151 | $11 |
Money from drug and device companies
$516 in 2025
| 2025 | 4 | 5 | None | $516 |
| 2024 | 4 | 7 | None | $241 |
| 2023 | 1 | 10 | None | $140 |
| 2022 | 2 | 11 | $148 | $239 |
| 2021 | 3 | 34 | $677 | $923 |
| 2020 | 2 | 29 | $267 | $383 |
| 2019 | 4 | 5 | $24 | $104 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Si-Bone | Ifuse Implant System | $352 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $93 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $37 | 2 payments
|
| Vertex Pharmaceuticals | Journavx | $34 | 1 payment
|
See all 5 published payments
| Si-Bone | Travel · 2025-12-11 | Ifuse Implant System | $352 |
| SPR Therapeutics | Meals · 2025-09-12 | Sprint Pns System | $93 |
| Vertex Pharmaceuticals | Meals · 2025-06-25 | Journavx | $34 |
| Collegium Pharmaceutical | Meals · 2025-04-25 | Belbuca | $18 |
| Collegium Pharmaceutical | Meals · 2025-02-10 | Belbuca | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $241
| Revance Therapeutics | Daxxify | $122 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $75 | 4 payments
|
| Vertex Pharmaceuticals | None | $29 | 1 payment
|
| Abbott Laboratories | Proclaim | $15 | 1 payment
|
2023: $140
| Collegium Pharmaceutical | Belbuca | $140 | 10 payments
|
2022: $239
| Djo | Procare | $148 | 6 payments
|
| Collegium Pharmaceutical | Xtampza | $91 | 5 payments
|
2021: $923
| Djo | Aircast Bracing & Supports | $677 | 27 payments
|
| Abbott Laboratories | Proclaim Ipg | $153 | 2 payments
|
| Collegium Pharmaceutical | Xtampza | $93 | 5 payments
|
2020: $383
| Djo | None | $267 | 21 payments
|
| Collegium Pharmaceutical | Xtampza | $116 | 8 payments
|
2019: $104
| DePuy Synthes Sales | Monovisc | $30 | 1 payment
|
| Si-Bone | Ifuse Implant | $26 | 1 payment
|
| Boston Scientific | General Pain Management | $24 | 1 payment
|
| Djo | None | $24 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1861572943
- Licence
- CA A75751California A75751: Current · expires 2027-02-28
- Trained
- Tufts University School of Medicine, 1996
- Group
- Sutter Bay Medical Foundation · California Sports and Orthopaedic
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208100000X (208100000X)
- Mailing address
- 3300 Webster St, #702, Oakland, CA, 94609
- NPI first listed
- 2006-10-16
- NPI last updated
- 2008-04-24
This is when the NPI record was last certified, not a medical board exam.